Aven‐mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1555-2039|236|3|348-359

ISSN： 0022-3417

Source： THE JOURNAL OF PATHOLOGY, Vol.236, Iss.3, 2015-07, pp. : 348-359

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells

By  

Urologia Internationalis, Vol. 86, Iss. 3, 2011-01 ,pp. : 346-354

Karger

Access to resources Recommend Favorite

Phosphatidylinositol 3-Kinase Inhibitor LY294002 Suppresses Proliferation and Sensitizes Doxorubicin Chemotherapy in Bladder Cancer Cells

By  

Urologia Internationalis, Vol. 87, Iss. 1, 2011-05 ,pp. : 105-113

Karger

Access to resources Recommend Favorite

Enteric duplication with osteosarcoma

By  

PEDIATRICS INTERNATIONAL, Vol. 56, Iss. 2, 2014-04 ,pp. : 279-282

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Status and Perspectives Regarding the Treatment of Osteosarcoma: Chemotherapy

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 3, 2008-09 ,pp. : 228-231

Bentham Science Publishers

Access to resources Recommend Favorite

Ras-MAP Kinase Signaling Pathways and Control of Cell Proliferation: Relevance to Cancer Therapy

By Shapiro Paul  

Critical Reviews in Clinical Laboratory Sciences, Vol. 39, Iss. 4-5, 2001-07 ,pp. : 285-330

Informa Healthcare

Access to resources Recommend Favorite